BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2083899)

  • 1. [Drug therapy of glaucoma].
    Krieglstein GK
    Fortschr Ophthalmol; 1990; 87 Suppl():S172-4. PubMed ID: 2083899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical therapy of primitive hypertensive glaucoma-therapeutic principles, perspectives].
    Cucea R
    Oftalmologia; 2006; 50(3):38-43. PubMed ID: 17144504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in the drug treatment of glaucoma.
    Hurvitz LM; Kaufman PL; Robin AL; Weinreb RN; Crawford K; Shaw B
    Drugs; 1991 Apr; 41(4):514-32. PubMed ID: 1711957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostanoids in the therapy of glaucoma.
    Ishida N; Odani-Kawabata N; Shimazaki A; Hara H
    Cardiovasc Drug Rev; 2006; 24(1):1-10. PubMed ID: 16939629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure].
    Oberacher-Velten I; Zeman F; Lehmann F; Barth T; Peters P; Helbig H; Greslechner R
    Ophthalmologe; 2017 Jul; 114(7):632-638. PubMed ID: 27848008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timolol + latanoprost: new preparation. Last-resort eye drops.
    Prescrire Int; 2003 Oct; 12(67):173-4. PubMed ID: 14619889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G; Kóthy P
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of glaucoma and the promising perspectives.
    Diestelhorst M
    Curr Opin Ophthalmol; 1996 Apr; 7(2):18-23. PubMed ID: 10163316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications.
    De Natale R; Draghi E; Dorigo MT
    Acta Ophthalmol Scand; 2004 Aug; 82(4):393-6. PubMed ID: 15291930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of medical management in chronic open angle glaucoma.
    Sugar HS
    Ann Ophthalmol; 1971 Jun; 3(6):579-86. PubMed ID: 5164431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N; Grehn F; Hennekes R; Garus H
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
    Nakakura S; Nomura Y; Ataka S; Shiraki K
    J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The medical treatment of glaucoma].
    Sapir-Pichhadze R; Blumenthal E
    Harefuah; 2003 Jan; 142(1):66-9, 76. PubMed ID: 12647493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.